Article
Impact of the Maraviroc-Resistant Mutation M434I in the C4 Region of HIV-1 gp120 on Sensitivity to Antibody-Mediated Neutralization.
Japanese journal of infectious diseases - 20 May 2016
Boonchawalit Samatchaya, Harada Shigeyoshi, Shirai Noriko, Gatanaga Hiroyuki, Oka Shinichi, Matsushita Shuzo, Yoshimura Kazuhisa
Abstract excerpt
We previously reported that a maraviroc (MVC)-resistant human immunodeficiency virus type 1variant, generated using in vitro selection, exhibited high sensitivity to several neutralizing monoclonal antibodies (NMAbs) and autologous plasma IgGs. The MVC-resistant variant acquired 4 sequential mutations in gp120: T297I, M434I, V200I, and K305R. In this study, we examined the mutation most responsible for conferring...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
